Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

Completed

Conditions: Lung Cancer
Ovarian Cancer
Breast Cancer
Hodgkin's Disease
Neuroblastoma

Interventions: Other: Symptom Assessment Scale

First Posted Date: 2008-02-06

Last Posted Date: 2009-11-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 121

Registration Number: NCT00608452

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device

Completed

Conditions: Cancer

Interventions: Other: hand-held POC creatinine analyzer-blood test

First Posted Date: 2008-02-05

Last Posted Date: 2010-06-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 99

Registration Number: NCT00607529

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy

Completed

Conditions: Acute Myeloid Leukemia
Acute Undifferentiated Leukemia
Biphenotypic Leukemia
Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma

Interventions: Procedure: MRI and cognitive evaluation
Procedure: brain MRI study and a brief neuropsychological evaluation

First Posted Date: 2008-02-01

Last Posted Date: 2015-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 66

Registration Number: NCT00606216

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Weill Cornell Medical Center, New York, New York, United States

Breast MRI as a Preoperative Tool for DCIS

Not Applicable

Active, not recruiting

Conditions: Ductal Carcinoma in Situ
Breast Cancer

Interventions: Procedure: MRI

First Posted Date: 2008-02-01

Last Posted Date: 2024-11-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 115

Registration Number: NCT00605982

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Not Applicable

Completed

Conditions: Head and Neck Cancer

Interventions: Radiation: fluorine-18-labeled fluoro-misonidazole (18F-FMISO)
Device: 18F-FMISO PET scan
Device: MRI
Device: FDG PET/CT scan

First Posted Date: 2008-02-01

Last Posted Date: 2023-06-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 216

Registration Number: NCT00606294

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States

and more 2 locations

Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery

Completed

Conditions: Breast Cancer
Breast Surgery
Breast Reconstruction
Breast Reduction
Breast Augmentation

Interventions: Behavioral: questionnaires

First Posted Date: 2008-01-31

Last Posted Date: 2013-11-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 722

Registration Number: NCT00605670

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Dartmouth Medical Center, Lebanon, New Hampshire, United States

and more 2 locations

Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function

Withdrawn

Conditions: Liver Cancer

Interventions: Other: blood drawn

First Posted Date: 2008-01-31

Last Posted Date: 2009-03-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00605800

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Radiation: PET Imaging With Cu-64 Labeled Trastuzumab

First Posted Date: 2008-01-31

Last Posted Date: 2015-12-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT00605397

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer
Breast Cancer
Head and Neck Cancer

Interventions: Procedure: novel PET tracer FACBC

First Posted Date: 2008-01-31

Last Posted Date: 2017-04-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT00605488

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Radiation: High dose rate (HDR) brachytherapy using Iridium 192 radioactive seeds

First Posted Date: 2008-01-30

Last Posted Date: 2016-01-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT00604526

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy